Orlando Santana
Psychiatry · Hialeah, FLNPI 1831249390
Payments from drug & device makers
Across 225 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$797
- Otsuka America Pharmaceutical, Inc.$793
- Johnson & Johnson$522
- AbbVie$480
- Teva Pharmaceuticals USA, Inc.$466
- Neurocrine Biosciences, Inc.$465
- plus $1K from 10 others
What the payments were for
- Food & beverage$4,915100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 39 | $797 |
| Otsuka America Pharmaceutical, Inc. | 37 | $793 |
| Johnson & Johnson | 20 | $522 |
| AbbVie | 27 | $480 |
| Teva Pharmaceuticals USA, Inc. | 20 | $466 |
| Neurocrine Biosciences, Inc. | 20 | $465 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $325 |
| E.r. Squibb & Sons, L.L.C. | 14 | $304 |
| Almatica Pharma LLC | 12 | $254 |
| Vanda Pharmaceuticals Inc. | 7 | $185 |
| Axsome Therapeutics, Inc. | 6 | $121 |
| Indivior Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $70 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
How this compares
$4,915 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 31 | $215,212 |
| Invega SustennaPaliperidone Palmitate | 62 | $165,988 |
| RexultiBrexpiprazole | 119 | $163,994 |
| Abilify MaintenaAripiprazole | 36 | $83,693 |
| VraylarCariprazine Hcl | 57 | $83,415 |
| AristadaAripiprazole Lauroxil | 30 | $63,675 |
| Aripiprazole | 531 | $57,069 |
| FanaptIloperidone | 33 | $47,744 |
| LybalviOlanzapine/Samidorphan Malate | 27 | $42,517 |
| Lurasidone Hcl | 159 | $38,347 |
| LibraxChlordiazepoxide/Clidinium Br | 17 | $29,279 |
| Chlorpromazine Hcl | 137 | $26,487 |
| Olanzapine | 695 | $26,011 |
| LatudaLurasidone Hcl | 14 | $23,491 |
| CaplytaLumateperone Tosylate | 15 | $22,543 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $793 | $247,687155 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $465 | $215,21231 claims |
| Johnson & JohnsonInvega Sustenna | $522 | $165,98862 claims |
| Alkermes, Inc.Aristada, Lybalvi | $797 | $106,19157 claims |
| AbbVieVraylar | $480 | $83,41557 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $185 | $47,74433 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $19 | $23,49114 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $325 | $22,54315 claims |
| Axsome Therapeutics, Inc.Auvelity | $121 | $8,61716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Hialeah
- Jose GamezHialeah$14.8M
- Kenia CastroHialeah$4.3M
- Junior PittackHialeah$1.7M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.